Cargando…

Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects

SIMPLE SUMMARY: Macrophages exert a dual role in tumor progression. Macrophage-centered immunotherapies, including immune checkpoints (ICs) stimulation and inhibition, have demonstrated promising clinical perspectives. However, due to immune or metastatic heterogeneity, different cancer patients res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yuanyuan, Zhang, Weijie, Lan, Peixiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736575/ https://www.ncbi.nlm.nih.gov/pubmed/36497444 http://dx.doi.org/10.3390/cancers14235963

Ejemplares similares

Receptor–ligand pair typing and prognostic risk model of response or resistance to immune checkpoint inhibitors in lung adenocarcinoma
por: Mao, Shengqiang, et al.
Publicado: (2023)

Immune Checkpoint Receptor/Ligand Expression and Chemotherapy in Colorectal Cancer
por: Benelli, Roberto, et al.
Publicado: (2023)

Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands
por: Kamali, Ali N., et al.
Publicado: (2023)

The CC′ loop of IgV domains of the immune checkpoint receptors, plays a key role in receptor:ligand affinity modulation
por: Kundapura, Shankar V., et al.
Publicado: (2019)

Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

Immunoregulation of macrophages by dynamic ligand presentation via ligand–cation coordination
por: Kang, Heemin, et al.
Publicado: (2019)

Expression Analysis of Ligand-Receptor Pairs Identifies Cell-to-Cell Crosstalk between Macrophages and Tumor Cells in Lung Adenocarcinoma
por: Yang, Xiaodong, et al.
Publicado: (2022)

Predicting receptor-ligand pairs through kernel learning
por: Iacucci, Ernesto, et al.
Publicado: (2011)

Regulation of Monocyte-Macrophage Responses in Cirrhosis—Role of Innate Immune Programming and Checkpoint Receptors
por: Riva, Antonio, et al.
Publicado: (2019)

The molecular subtypes of triple negative breast cancer were defined and a ligand-receptor pair score model was constructed by comprehensive analysis of ligand-receptor pairs
por: Pan, Weijun, et al.
Publicado: (2022)

Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas
por: Dancsok, Amanda R., et al.
Publicado: (2020)

Modulation of Immune Responses by Nutritional Ligands of Aryl Hydrocarbon Receptor
por: De Juan, Alba, et al.
Publicado: (2021)

PD-1 and its ligands are important immune checkpoints in cancer
por: Dong, Yinan, et al.
Publicado: (2016)

Perspectives on immune checkpoint ligands: expression, regulation, and clinical implications
por: Moon, Jihyun, et al.
Publicado: (2021)

P591: EXPRESSION PATTERNS AND CLINICAL RELEVANCE OF IMMUNE CHECKPOINT RECEPTORS AND LIGANDS IN ACUTE MYELOID LEUKEMIA
por: Jagurinoski, Milan, et al.
Publicado: (2023)

Deactivation of ligand-receptor interactions enhancing lymphocyte infiltration drives melanoma resistance to Immune Checkpoint Blockade
por: Sahni, Sahil, et al.
Publicado: (2023)

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
por: Shi, An-Ping, et al.
Publicado: (2022)

IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
por: Tang, Xi-Yang, et al.
Publicado: (2022)

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
por: Xu, Shumin, et al.
Publicado: (2023)

The Immune Checkpoint Receptor CD96: A Local and Systemic Immune Modulator in Oral Cancer?
por: Trumet, Leah, et al.
Publicado: (2023)

Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy
por: Zhou, Xuefei, et al.
Publicado: (2021)

Optimization of rice panicle architecture by specifically suppressing ligand–receptor pairs
por: Guo, Tao, et al.
Publicado: (2023)

Activation of immune signals during organ transplantation
por: Li, Qingwen, et al.
Publicado: (2023)

Immune checkpoint receptors: homeostatic regulators of immunity
por: Riva, Antonio, et al.
Publicado: (2018)

Tamoxifen Modulates the Immune Landscape of the Tumour Microenvironment: The Paired Siglec-5/14 Checkpoint in Anti-Tumour Immunity in an In Vitro Model of Breast Cancer
por: Wielgat, Przemyslaw, et al.
Publicado: (2023)

Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma
por: Aicher, Wilhelm K., et al.
Publicado: (2021)

The Features of Checkpoint Receptor—Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition
por: Kuzevanova, Anna, et al.
Publicado: (2022)

Immune Checkpoint Receptors Signaling in T Cells
por: Baldanzi, Gianluca
Publicado: (2022)

Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions
por: Alberti, Dafne, et al.
Publicado: (2021)

Large-Scale G Protein-Coupled Olfactory Receptor–Ligand Pairing
por: Cong, Xiaojing, et al.
Publicado: (2022)

Rapid and accurate deorphanization of ligand-receptor pairs using AlphaFold
por: Danneskiold-Samsøe, Niels Banhos, et al.
Publicado: (2023)

New Insights into Ligand-Receptor Pairing and Coevolution of Relaxin Family Peptides and Their Receptors in Teleosts
por: Good, Sara, et al.
Publicado: (2012)

Paired opposing leukocyte receptors recognizing rapidly evolving ligands are subject to homogenization of their ligand binding domains
por: Fossum, Sigbjørn, et al.
Publicado: (2011)

Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium
por: Kim, Eileen S., et al.
Publicado: (2016)

T lymphocyte-targeted immune checkpoint modulation in glioma
por: Kelly, William James, et al.
Publicado: (2020)

Gut microbiome in modulating immune checkpoint inhibitors
por: Li, Xiang, et al.
Publicado: (2022)

The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
por: Williams, Patrick, et al.
Publicado: (2018)

The Promiscuous Profile of Complement Receptor 3 in Ligand Binding, Immune Modulation, and Pathophysiology
por: Lamers, Christina, et al.
Publicado: (2021)

Transport of macrophage Fc receptors and Fc receptor-bound ligands to lysosomes
Publicado: (1986)

Current progress and prospect of immune checkpoint inhibitors in hepatocellular carcinoma
por: Zeng, Zhu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_660gd6r0ds3l08m0ho69sqk60d